Phenobarbitone enhances [35S]TBPS binding to extensively washed rat cortical membranes

Area of Science:

• Neuropharmacology
• Neuroscience
• Molecular Biology

Background:

• The gamma-aminobutyric acid (GABA) receptor is a primary inhibitory neurotransmitter receptor in the central nervous system.
• GABA receptor function is modulated by various drugs, including barbiturates, affecting neuronal excitability.
• Understanding the precise mechanisms of barbiturate interaction with the GABA receptor is crucial for developing targeted therapeutics.

Purpose of the Study:

• To investigate the interaction of pentobarbitone and phenobarbitone with the GABA receptor chloride ionophore.
• To determine if these barbiturates bind to the same site as the radioligand [35S]TBPS.
• To elucidate the allosteric coupling between barbiturate binding sites and the TBPS binding site on the GABA receptor.

Main Methods:

• Utilizing extensively washed rat cortical membranes for receptor binding assays.
• Quantifying the enhancement of [35S]TBPS binding in the presence of varying concentrations of pentobarbitone and phenobarbitone.
• Calculating the median effective dose (ED50) values for the observed enhancement.

Main Results:

• Pentobarbitone enhanced [35S]TBPS binding with an ED50 of 15 microM.
• Phenobarbitone enhanced [35S]TBPS binding with an ED50 of 120 microM.
• These results indicate that both drugs interact with the chloride ionophore component of the GABA receptor.

Conclusions:

• Pentobarbitone and phenobarbitone allosterically modulate the GABA receptor.
• Their interaction occurs at a site distinct from, yet coupled to, the [35S]TBPS binding site on the chloride ionophore.
• This allosteric modulation provides insights into the complex pharmacology of barbiturates and the GABA receptor complex.